APEX SMILES LIMITED
Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
Corporate timeline (8 events)Click to expand
- 2025-10-15📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-12-11📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-01-02📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2024-01-02📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2023-12-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-03-27🏢Company incorporatedAs APEX SMILES LIMITED
- 2022-03-27➕SHAN, Janayd appointeddirector
- 2022-03-27📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Miss Ayesha Mohiuddin Individual · British · DOB 04/1997 · age 29 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 15/12/2023 |
Mr Janayd Shan Individual · British · DOB 11/1994 · age 32 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 27/03/2022 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · LU postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A&A HOMECARE LTD→ 11137820 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| ALTHORP MEDCARE LIMITED→ 16944468 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AMEERAH HEALTHCARE LTD→ 16662810 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AMELIORATE EMS LTD→ 15439963 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ANUGBULE & SONS LTD→ 14476285 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| APEX CARE GROUP LIMITED→ 12672311 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| APRILIS SUPPORT CARE LIMITED→ 14144625 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| APT CARE (BEDFORD) LIMITED→ 09233410 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| APT CARE LIMITED→ 05817556 · est 2006 · no financials extracted | — | — | — | — | 19y | — | — |
| AR THERAPY LTD→ 11951575 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| ARGCARE LIMITED→ 12163122 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ARISE HEALTHCARE LTD→ 16359311 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.